← Evidence library

UK-REBOA

Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta in Trauma Patients With Exsanguinating Hemorrhage: The UK-REBOA Randomized Clinical Trial.

Jansen JO, Hudson J, Cochran C, et al. JAMA 2023 · PMID 37824132 · doi:10.1001/jama.2023.20850

Randomised trialManagementMajor trauma & polytraumaCitation checked
Question
Does adding REBOA to standard care in the emergency department reduce death in trauma patients with exsanguinating haemorrhage?
Design
Pragmatic Bayesian multicentre RCT in UK major trauma centres, funded by the NIHR.
Patients
Adult trauma patients with suspected exsanguinating haemorrhage below the diaphragm unresponsive to resuscitation.
Intervention
REBOA plus standard major trauma care
Comparison
Standard major trauma care alone
Primary outcome
All-cause mortality at 90 days
Key result
REBOA did not reduce mortality; the Bayesian analysis showed a high probability of harm, with more deaths, many occurring early from bleeding.
Limitations
Recruitment was smaller than planned and stopped early, and operators had limited REBOA experience, which may not reflect expert centres.
Impact on practice
Does not support routine emergency department REBOA in UK trauma care; haemorrhage control should focus on rapid definitive surgical or radiological intervention.
Practise 7 questions on this paper →Read the paper ↗